ID   ENDOU_HUMAN             Reviewed;         410 AA.
AC   P21128; B2RBJ3; B3KQS7; B7Z6E1; Q2NKJ4;
DT   01-FEB-1991, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 2.
DT   18-JUN-2025, entry version 191.
DE   RecName: Full=Uridylate-specific endoribonuclease {ECO:0000305|PubMed:18936097};
DE            EC=3.1.-.- {ECO:0000255|PROSITE-ProRule:PRU01304};
DE            EC=4.6.1.- {ECO:0000269|PubMed:18936097};
DE   AltName: Full=Placental protein 11;
DE            Short=PP11;
DE   AltName: Full=Protein endoU;
DE   Flags: Precursor;
GN   Name=ENDOU;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND PROTEIN SEQUENCE OF N-TERMINUS.
RC   TISSUE=Placenta;
RX   PubMed=2350438; DOI=10.1089/dna.1990.9.243;
RA   Grundmann U., Roemisch J., Siebold B., Bohn H., Amann E.;
RT   "Cloning and expression of a cDNA encoding human placental protein 11, a
RT   putative serine protease with diagnostic significance as a tumor marker.";
RL   DNA Cell Biol. 9:243-250(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3).
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M., Kovar-Smith C.,
RA   Lewis L.R., Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R.,
RA   Montgomery K.T., Morgan M.B., Nazareth L.V., Scott G., Sodergren E.,
RA   Song X.-Z., Steffen D., Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y.,
RA   Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G.,
RA   Chen Z., Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H.,
RA   Draper H., Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S.,
RA   Kelly S.H., Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M.,
RA   Nguyen B.-V., Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H.,
RA   Santibanez J., Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q.,
RA   Williams G.A., Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V.,
RA   Bailey M., Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E.,
RA   Burkett C.E., Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M., Dathorne S.R.,
RA   David R., Davis C.M., Davy-Carroll L., Deshazo D.R., Donlin J.E.,
RA   D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J., Escotto M., Flagg N.,
RA   Forbes L.D., Gabisi A.M., Garza M., Hamilton C., Henderson N.,
RA   Hernandez O., Hines S., Hogues M.E., Huang M., Idlebird D.G., Johnson R.,
RA   Jolivet A., Jones S., Kagan R., King L.M., Leal B., Lebow H., Lee S.,
RA   LeVan J.M., Lewis L.C., London P., Lorensuhewa L.M., Loulseged H.,
RA   Lovett D.A., Lucier A., Lucier R.L., Ma J., Madu R.C., Mapua P.,
RA   Martindale A.D., Martinez E., Massey E., Mawhiney S., Meador M.G.,
RA   Mendez S., Mercado C., Mercado I.C., Merritt C.E., Miner Z.L., Minja E.,
RA   Mitchell T., Mohabbat F., Mohabbat K., Montgomery B., Moore N., Morris S.,
RA   Munidasa M., Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O.,
RA   Nwokenkwo S., Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D., Trejos Z.Y.,
RA   Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I., Vera V.A.,
RA   Villasana D.M., Wang L., Ward-Moore S., Warren J.T., Wei X., White F.,
RA   Williamson A.L., Wleczyk R., Wooden H.S., Wooden S.H., Yen J., Yoon L.,
RA   Yoon V., Zorrilla S.E., Nelson D., Kucherlapati R., Weinstock G.,
RA   Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   DOMAIN SOMATOMEDIN-B.
RX   PubMed=1710108; DOI=10.1016/0006-291x(91)90381-g;
RA   Jenne D.E.;
RT   "Homology of placental protein 11 and pea seed albumin 2 with
RT   vitronectin.";
RL   Biochem. Biophys. Res. Commun. 176:1000-1006(1991).
RN   [7]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBSTRATE SPECIFICITY, RNA-BINDING, COFACTOR,
RP   AND MUTAGENESIS OF GLU-284; HIS-285; GLU-290; HIS-300 AND LYS-343.
RX   PubMed=18936097; DOI=10.1074/jbc.m805759200;
RA   Laneve P., Gioia U., Ragno R., Altieri F., Di Franco C., Santini T.,
RA   Arceci M., Bozzoni I., Caffarelli E.;
RT   "The tumor marker human placental protein 11 is an endoribonuclease.";
RL   J. Biol. Chem. 283:34712-34719(2008).
RN   [8]
RP   FUNCTION.
RX   PubMed=37803019; DOI=10.1038/s41467-023-42042-7;
RA   Sun X., Shen J., Perrimon N., Kong X., Wang D.;
RT   "The endoribonuclease Arlr is required to maintain lipid homeostasis by
RT   downregulating lipolytic genes during aging.";
RL   Nat. Commun. 14:6254-6254(2023).
CC   -!- FUNCTION: Endoribonuclease that cleaves single-stranded RNAs at 5' of
CC       uridylates and releases a product with a 2',3'-cyclic phosphate at the
CC       3'-end. The UU and GU sites are more efficiently cleaved than CU and AU
CC       sites (PubMed:18936097). Targets mRNAs to regulate their expression
CC       (PubMed:37803019). {ECO:0000269|PubMed:18936097,
CC       ECO:0000269|PubMed:37803019}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ribonucleotidyl-uridine-RNA = a 5'-end dephospho-uridine-RNA +
CC         a 3'-end 2',3'-cyclophospho-ribonucleotide-RNA; Xref=Rhea:RHEA:67792,
CC         Rhea:RHEA-COMP:10464, Rhea:RHEA-COMP:17354, Rhea:RHEA-COMP:17356,
CC         ChEBI:CHEBI:83064, ChEBI:CHEBI:173117, ChEBI:CHEBI:173224;
CC         Evidence={ECO:0000269|PubMed:18936097};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:67793;
CC         Evidence={ECO:0000305|PubMed:18936097};
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000269|PubMed:18936097};
CC   -!- SUBUNIT: Monomer. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P21128-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P21128-2; Sequence=VSP_039216;
CC       Name=3;
CC         IsoId=P21128-3; Sequence=VSP_039215;
CC   -!- TISSUE SPECIFICITY: Placental-specific, but also associated with
CC       various malignant neoplasms.
CC   -!- PTM: It has been suggested that the active SMB domain may be permitted
CC       considerable disulfide bond heterogeneity or variability, thus two
CC       alternate disulfide patterns based on 3D structures are described with
CC       1 disulfide bond conserved in both.
CC   -!- SIMILARITY: Belongs to the ENDOU family. {ECO:0000255|PROSITE-
CC       ProRule:PRU01304}.
CC   -!- CAUTION: Was originally (PubMed:2350438) thought to be a serine
CC       protease. However, PubMed:18936097 showed it is not the case.
CC       {ECO:0000305|PubMed:2350438}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M32402; AAA36464.1; -; mRNA.
DR   EMBL; M36109; AAA36465.1; -; mRNA.
DR   EMBL; AK075446; BAG52139.1; -; mRNA.
DR   EMBL; AK300169; BAH13227.1; -; mRNA.
DR   EMBL; AK314688; BAG37240.1; -; mRNA.
DR   EMBL; AC004241; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471111; EAW57940.1; -; Genomic_DNA.
DR   EMBL; BC069715; AAH69715.1; -; mRNA.
DR   EMBL; BC074763; AAH74763.1; -; mRNA.
DR   EMBL; BC111782; AAI11783.1; -; mRNA.
DR   CCDS; CCDS53784.1; -. [P21128-3]
DR   CCDS; CCDS53785.1; -. [P21128-1]
DR   CCDS; CCDS8754.1; -. [P21128-2]
DR   PIR; A34614; A34614.
DR   RefSeq; NP_001165910.1; NM_001172439.2. [P21128-1]
DR   RefSeq; NP_001165911.1; NM_001172440.2. [P21128-3]
DR   RefSeq; NP_006016.1; NM_006025.4. [P21128-2]
DR   PDB; 9FTW; X-ray; 1.65 A; A/B=1-410.
DR   PDBsum; 9FTW; -.
DR   AlphaFoldDB; P21128; -.
DR   SMR; P21128; -.
DR   BioGRID; 114423; 29.
DR   FunCoup; P21128; 117.
DR   IntAct; P21128; 23.
DR   STRING; 9606.ENSP00000397679; -.
DR   MEROPS; X41.001; -.
DR   iPTMnet; P21128; -.
DR   PhosphoSitePlus; P21128; -.
DR   BioMuta; ENDOU; -.
DR   DMDM; 296434493; -.
DR   jPOST; P21128; -.
DR   MassIVE; P21128; -.
DR   PaxDb; 9606-ENSP00000397679; -.
DR   PeptideAtlas; P21128; -.
DR   PRIDE; P21128; -.
DR   ProteomicsDB; 53846; -. [P21128-1]
DR   ProteomicsDB; 53847; -. [P21128-2]
DR   ProteomicsDB; 53848; -. [P21128-3]
DR   TopDownProteomics; P21128-2; -. [P21128-2]
DR   Antibodypedia; 2843; 52 antibodies from 19 providers.
DR   DNASU; 8909; -.
DR   Ensembl; ENST00000229003.7; ENSP00000229003.3; ENSG00000111405.9. [P21128-2]
DR   Ensembl; ENST00000422538.8; ENSP00000397679.3; ENSG00000111405.9. [P21128-1]
DR   Ensembl; ENST00000545824.2; ENSP00000445004.2; ENSG00000111405.9. [P21128-3]
DR   GeneID; 8909; -.
DR   KEGG; hsa:8909; -.
DR   MANE-Select; ENST00000422538.8; ENSP00000397679.3; NM_001172439.2; NP_001165910.1.
DR   UCSC; uc001rpt.3; human. [P21128-1]
DR   AGR; HGNC:14369; -.
DR   CTD; 8909; -.
DR   DisGeNET; 8909; -.
DR   GeneCards; ENDOU; -.
DR   HGNC; HGNC:14369; ENDOU.
DR   HPA; ENSG00000111405; Tissue enhanced (esophagus, vagina).
DR   MIM; 606720; gene.
DR   neXtProt; NX_P21128; -.
DR   OpenTargets; ENSG00000111405; -.
DR   PharmGKB; PA165512645; -.
DR   VEuPathDB; HostDB:ENSG00000111405; -.
DR   eggNOG; KOG2849; Eukaryota.
DR   GeneTree; ENSGT00530000063825; -.
DR   HOGENOM; CLU_048034_0_0_1; -.
DR   InParanoid; P21128; -.
DR   OMA; PGRACHL; -.
DR   OrthoDB; 430326at2759; -.
DR   PAN-GO; P21128; 1 GO annotation based on evolutionary models.
DR   PhylomeDB; P21128; -.
DR   TreeFam; TF319848; -.
DR   PathwayCommons; P21128; -.
DR   SignaLink; P21128; -.
DR   BioGRID-ORCS; 8909; 15 hits in 1147 CRISPR screens.
DR   GenomeRNAi; 8909; -.
DR   Pharos; P21128; Tbio.
DR   PRO; PR:P21128; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; P21128; protein.
DR   Bgee; ENSG00000111405; Expressed in lower esophagus mucosa and 116 other cell types or tissues.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:UniProtKB.
DR   GO; GO:0008083; F:growth factor activity; NAS:UniProtKB.
DR   GO; GO:0016829; F:lyase activity; IEA:UniProtKB-KW.
DR   GO; GO:0030145; F:manganese ion binding; TAS:UniProtKB.
DR   GO; GO:0030247; F:polysaccharide binding; IEA:InterPro.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0004521; F:RNA endonuclease activity; IDA:UniProtKB.
DR   GO; GO:0005044; F:scavenger receptor activity; IEA:InterPro.
DR   GO; GO:0008236; F:serine-type peptidase activity; IDA:UniProtKB.
DR   GO; GO:0007565; P:female pregnancy; IEP:UniProtKB.
DR   GO; GO:0006955; P:immune response; IEA:InterPro.
DR   GO; GO:0050995; P:negative regulation of lipid catabolic process; IGI:FlyBase.
DR   GO; GO:0016441; P:post-transcriptional gene silencing; IGI:FlyBase.
DR   GO; GO:0006508; P:proteolysis; IDA:UniProtKB.
DR   CDD; cd21159; XendoU; 1.
DR   FunFam; 4.10.410.20:FF:000005; Endonuclease, poly(U) specific; 1.
DR   FunFam; 4.10.410.20:FF:000007; Poly(U)-specific endoribonuclease; 1.
DR   Gene3D; 4.10.410.20; -; 2.
DR   InterPro; IPR039787; ENDOU.
DR   InterPro; IPR037227; EndoU-like.
DR   InterPro; IPR018998; EndoU_C.
DR   InterPro; IPR020436; SMB_chordata.
DR   InterPro; IPR036024; Somatomedin_B-like_dom_sf.
DR   InterPro; IPR001212; Somatomedin_B_dom.
DR   PANTHER; PTHR12439; PLACENTAL PROTEIN 11-RELATED; 1.
DR   PANTHER; PTHR12439:SF40; URIDYLATE-SPECIFIC ENDORIBONUCLEASE; 1.
DR   Pfam; PF01033; Somatomedin_B; 2.
DR   Pfam; PF09412; XendoU; 1.
DR   PRINTS; PR00022; SOMATOMEDINB.
DR   SMART; SM00201; SO; 2.
DR   SUPFAM; SSF142877; EndoU-like; 1.
DR   SUPFAM; SSF90188; Somatomedin B domain; 2.
DR   PROSITE; PS51959; ENDOU; 1.
DR   PROSITE; PS00524; SMB_1; 2.
DR   PROSITE; PS50958; SMB_2; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Direct protein sequencing;
KW   Disulfide bond; Endonuclease; Hydrolase; Lyase; Manganese; Metal-binding;
KW   Nuclease; Proteomics identification; Reference proteome; Repeat;
KW   RNA-binding; Secreted; Signal.
FT   SIGNAL          1..18
FT                   /evidence="ECO:0000269|PubMed:2350438"
FT   CHAIN           19..410
FT                   /note="Uridylate-specific endoribonuclease"
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_0000036405"
FT   DOMAIN          20..62
FT                   /note="SMB 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00350"
FT   DOMAIN          86..130
FT                   /note="SMB 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00350"
FT   DOMAIN          137..410
FT                   /note="EndoU"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01304"
FT   ACT_SITE        285
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01304"
FT   ACT_SITE        300
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01304"
FT   ACT_SITE        343
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01304"
FT   DISULFID        24..40
FT                   /note="Alternate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00350"
FT   DISULFID        24..28
FT                   /note="Alternate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00350"
FT   DISULFID        28..58
FT                   /note="Alternate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00350"
FT   DISULFID        38..51
FT                   /note="Alternate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00350"
FT   DISULFID        38..40
FT                   /note="Alternate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00350"
FT   DISULFID        44..50
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00350"
FT   DISULFID        51..58
FT                   /note="Alternate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00350"
FT   DISULFID        90..106
FT                   /note="Alternate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00350"
FT   DISULFID        90..94
FT                   /note="Alternate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00350"
FT   DISULFID        94..124
FT                   /note="Alternate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00350"
FT   DISULFID        104..117
FT                   /note="Alternate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00350"
FT   DISULFID        104..106
FT                   /note="Alternate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00350"
FT   DISULFID        110..116
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00350"
FT   DISULFID        117..124
FT                   /note="Alternate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00350"
FT   VAR_SEQ         19..82
FT                   /note="GKIESCASRCNEKFNRDAACQCDRRCLWHGNCCEDYEHLCTEDHKESEPLPQ
FT                   LEEETEEALASN -> D (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_039215"
FT   VAR_SEQ         19..59
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:2350438"
FT                   /id="VSP_039216"
FT   MUTAGEN         284
FT                   /note="E->Q: Abolishes endoribonuclease activity and
FT                   increases RNA-binding activity."
FT                   /evidence="ECO:0000269|PubMed:18936097"
FT   MUTAGEN         285
FT                   /note="H->A: Abolishes endoribonuclease activity without
FT                   affecting RNA-binding activity."
FT                   /evidence="ECO:0000269|PubMed:18936097"
FT   MUTAGEN         290
FT                   /note="E->Q: Abolishes endoribonuclease activity without
FT                   affecting RNA-binding activity."
FT                   /evidence="ECO:0000269|PubMed:18936097"
FT   MUTAGEN         300
FT                   /note="H->A: Abolishes endoribonuclease activity without
FT                   affecting RNA-binding activity."
FT                   /evidence="ECO:0000269|PubMed:18936097"
FT   MUTAGEN         343
FT                   /note="K->A: Strongly impairs endoribonuclease activity
FT                   without affecting RNA-binding activity."
FT                   /evidence="ECO:0000269|PubMed:18936097"
FT   CONFLICT        123
FT                   /note="L -> P (in Ref. 2; BAG37240)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        387
FT                   /note="Y -> H (in Ref. 2; BAG37240)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   410 AA;  46872 MW;  CC19484F40355129 CRC64;
     MRACISLVLA VLCGLAWAGK IESCASRCNE KFNRDAACQC DRRCLWHGNC CEDYEHLCTE
     DHKESEPLPQ LEEETEEALA SNLYSAPTSC QGRCYEAFDK HHQCHCNARC QEFGNCCKDF
     ESLCSDHEVS HSSDAITKEE IQSISEKIYR ADTNKAQKED IVLNSQNCIS PSETRNQVDR
     CPKPLFTYVN EKLFSKPTYA AFINLLNNYQ RATGHGEHFS AQELAEQDAF LREIMKTAVM
     KELYSFLHHQ NRYGSEQEFV DDLKNMWFGL YSRGNEEGDS SGFEHVFSGE VKKGKVTGFH
     NWIRFYLEEK EGLVDYYSHI YDGPWDSYPD VLAMQFNWDG YYKEVGSAFI GSSPEFEFAL
     YSLCFIARPG KVCQLSLGGY PLAVRTYTWD KSTYGNGKKY IATAYIVSST
//
